Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Multisensory Approaches for Managing Pediatric Dental Anxiety

23 de septiembre de 2026 actualizado por: Mustafa Sarp Kaya, Bezmialem Vakif University

Evaluation of the Effects of Virtual Reality and Weighted Blanket Use on Dental Anxiety Among School-Aged Children With High Dental Anxiety

The purpose of this prospective, randomized, single-blind clinical study is to evaluate and compare the effectiveness of distraction using virtual reality (VR) glasses and deep-pressure stimulation using weighted blankets on dental anxiety, cooperation, and pain perception in school-aged children. The study focuses on children aged 5-9 years with high dental anxiety (CFSS-DS score ≥39) who require dental procedures involving local anesthesia, such as Class II restorations, pulpotomy, or extractions. Participants will be randomly assigned to four groups: a control group receiving standard behavior guidance, a VR group, a weighted blanket group, and a combined group using both VR and weighted blankets. The study aims to determine the effects of these non-pharmacological, non-invasive, sensory-based interventions on children's clinical experience and physiological parameters.

Descripción general del estudio

Descripción detallada

This clinical trial is designed as a four-arm, randomized controlled study to compare sensory-based behavior guidance techniques in pediatric dentistry.

Study Arms:

Group 1 (Control): Treatment with basic behavior guidance techniques.

Group 2 (VR): Treatment using virtual reality (VR) glasses as a distraction tool.

Group 3 (WB): Treatment using a 3-kg weighted blanket for deep-pressure stimulation.

Group 4 (Combined): Simultaneous use of VR glasses and a weighted blanket.

Methodology:

Children aged 5-9 years who meet the inclusion criteria will be evaluated at multiple time points: pre-treatment, during local anesthesia, and post-treatment.

Outcome Measures:

Dental Anxiety: Assessed using the Facial Image Scale (FIS) and the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS).

Cooperation: Evaluated using the Frankl Behavior Rating Scale and the FLACC (Face, Legs, Activity, Cry, Consolability) scale.

Pain Perception: Measured using the Wong-Baker FACES Pain Rating Scale.

Physiological Parameters: Heart rate and oxygen saturation will be monitored throughout the procedure.

Acceptability: Subjective feedback from children and parents will be collected via post-treatment surveys to assess the feasibility of and satisfaction with the interventions.

Inclusion is restricted to systemically healthy children (ASA I-II) whose body weight (15-30 kg) is compatible with the 3-kg weighted blanket to ensure safety and appropriate therapeutic pressure.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

  • Nombre: Mustafa Sarp Kaya, Associate Professor
  • Número de teléfono: +90 532 230 68 01
  • Correo electrónico: mskaya@bezmialem.edu.tr

Ubicaciones de estudio

    • Fatih
      • Istanbul, Fatih, Turquía (Türkiye), 34093
        • Reclutamiento
        • Bezm-i Alem Vakif University, Faculty of Dentistry, Department of Pediatric Dentistry

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

5 años a 9 años (Niño)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Children aged between 5 and 9 years.
  • Children with a total score of 39 or higher on the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS).
  • Requirement for dental treatment necessitating local anesthesia, such as Class II restorations, pulpotomy, pulpectomy, or extractions.
  • Systemically healthy children classified as ASA I or ASA II.
  • Voluntary participation of both the child and the parent, with written informed consent obtained from the parent.
  • Body weight between 15 and 30 kg, ensuring that the 3-kg weighted blanket corresponds to 10-20% of the child's body weight.

Exclusion Criteria:

  • Children with a CFSS-DS score of 38 or lower.
  • Presence of intellectual or developmental disabilities.
  • Presence of visual or hearing impairments.
  • Presence of neurodevelopmental or neurological disorders, such as epilepsy.
  • Acute or chronic respiratory diseases.
  • Neuromuscular or orthopedic conditions that may pose a risk during the use of the weighted blanket.
  • History of dizziness, nausea, or vertigo associated with virtual reality use.
  • Refusal of the specific interventions, namely VR glasses or the weighted blanket, by the child or the parent.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: Control Group

Participants in this group will receive dental treatment using only basic behavior guidance techniques, such as tell-show-do and positive reinforcement, without any additional sensory interventions.

Traditional non-pharmacological behavior management techniques, including the "Tell-Show-Do" method, positive reinforcement, and distraction through verbal communication, will be used as a standard protocol.

Experimental: Virtual Reality Group

Participants will wear virtual reality (VR) glasses during the dental procedure. The VR system will be used as a visual and auditory distraction tool to reduce dental anxiety and pain perception.

The participant will wear a Virtual Reality headset during the dental procedure. Audio-visual content specifically selected for pediatric distraction will be played to divert the child's attention away from dental stimuli and reduce anxiety.

Experimental: Weighted Blanket Group

Participants will be covered with a 3-kg weighted blanket during the dental procedure to provide deep-pressure stimulation. This non-pharmacological intervention aims to promote relaxation and reduce physiological stress responses.

A 3 kg weighted blanket will be placed over the participant's body during the dental treatment. This intervention aims to provide deep pressure stimulation to promote relaxation and decrease behavioral stress responses.

Experimental: Combined Intervention Group

Participants in this group will receive a combination of the two interventions during the entire dental procedure: virtual reality (VR) glasses for distraction and a weighted blanket for deep-pressure stimulation.

The participant will wear a Virtual Reality headset during the dental procedure. Audio-visual content specifically selected for pediatric distraction will be played to divert the child's attention away from dental stimuli and reduce anxiety.

A 3 kg weighted blanket will be placed over the participant's body during the dental treatment. This intervention aims to provide deep pressure stimulation to promote relaxation and decrease behavioral stress responses.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Children's Fear Survey Schedule-Dental Subscale (CFSS-DS) Score
Periodo de tiempo: During the dental examination session, before dental treatment.

Dental fear and anxiety will be assessed using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS). The total score ranges from 15 to 75, with higher scores indicating greater dental fear and anxiety.

During the dental examination session, before dental treatment.
Facial Image Scale (FIS) Score
Periodo de tiempo: Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.

Dental anxiety will be assessed using the Facial Image Scale (FIS), a 5-point facial image scale ranging from 1 to 5, with higher scores indicating greater dental anxiety. FIS scores will be recorded at three time points: immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.

Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.
Frankl Behavior Rating Scale Score
Periodo de tiempo: Immediately before dental treatment ande immediately after dental treatment.

Child behavior and cooperation during dental treatment will be assessed using the Frankl Behavior Rating Scale, which categorizes behavior into four levels ranging from definitely negative to definitely positive.

Immediately before dental treatment ande immediately after dental treatment.
FLACC Behavioral Pain Assessment Score
Periodo de tiempo: Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.

Pain-related behavioral responses will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) scale. The total score ranges from 0 to 10, with higher scores indicating greater pain-related behavioral response. Assessment will be performed by an independent evaluator blinded to group allocation using standardized video recordings.

Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.
Wong-Baker FACES Pain Rating Scale Score
Periodo de tiempo: Immediately before and immediately after local anesthetic injection.

Self-reported pain intensity will be assessed using the Wong-Baker FACES Pain Rating Scale, ranging from 0 to 10, with higher scores indicating greater pain intensity.

Immediately before and immediately after local anesthetic injection.
Heart Rate
Periodo de tiempo: Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.

Heart rate will be measured in beats per minute (bpm) using a pulse oximeter.

Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.
Peripheral Oxygen Saturation (SpO₂)
Periodo de tiempo: Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.

Peripheral oxygen saturation (SpO₂) will be measured using a pulse oximeter and recorded as percentage (%).

Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Mustafa Sarp Kaya, Associate Professor, Bezm-i Alem Vakif University, Faculty of Dentistry, Department of Pediatric Dentistry

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

19 de agosto de 2026

Finalización primaria (Estimado)

1 de abril de 2027

Finalización del estudio (Estimado)

1 de abril de 2027

Fechas de registro del estudio

Enviado por primera vez

23 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

23 de septiembre de 2026

Publicado por primera vez (Actual)

30 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

30 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

23 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be shared to protect participant confidentiality and privacy in accordance with the ethical committee approval and local data protection regulations.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir